A Strategy to Disentangle Direct and Indirect Effects on (de)phosphorylation by Chemical Modulators of the Phosphatase PP1 in Complex Cellular Contexts

Overview

Journal Chem Sci

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2024 Feb 26

PMID 38404380

Authors

Bernhard Hoermann

Eva-Maria Durr

Christina Ludwig

Melda Ercan

Maja Kohn

Affiliations

Soon will be listed here.

Abstract

Chemical activators and inhibitors are useful probes to identify substrates and downstream effects of enzymes; however, due to the complex signaling environment within cells, it is challenging to distinguish between direct and indirect effects. This is particularly the case for phosphorylation, where a single (de)phosphorylation event can trigger rapid changes in many other phosphorylation sites. An additional complication arises when a single catalytic entity, which acts in the form of many different holoenzymes with different substrates, is activated or inhibited, as it is unclear which holoenzymes are affected, and in turn which of their substrates are (de)phosphorylated. Direct target engaging MS-based technologies to study targets of drugs do not address these challenges. Here, we tackle this by studying the modulation of protein phosphatase-1 (PP1) activity by PP1-disrupting peptides (PDPs), as well as their selectivity toward PP1, by using a combination of mass spectrometry-based experiments. By combining cellular treatment with the PDP with dephosphorylation by the enzyme, we identify high confidence substrate candidates and begin to separate direct and indirect effects. Together with experiments analyzing which holoenzymes are particularly susceptible to this treatment, we obtain insights into the effect of the modulator on the complex network of protein (de)phosphorylation. This strategy holds promise for enhancing our understanding of PP1 in particular and, due to the broad applicability of the workflow and the MS-based read-out, of chemical modulators with complex mode of action in general.

References

Wu J, Guo J, Tang W, Yang C, Freel C, Chen C . PP1-mediated dephosphorylation of phosphoproteins at mitotic exit is controlled by inhibitor-1 and PP1 phosphorylation. Nat Cell Biol. 2009; 11(5):644-51. PMC: 2788612. DOI: 10.1038/ncb1871. View

Kremers G, Goedhart J, van Munster E, Gadella Jr T . Cyan and yellow super fluorescent proteins with improved brightness, protein folding, and FRET Förster radius. Biochemistry. 2006; 45(21):6570-80. DOI: 10.1021/bi0516273. View

Mellacheruvu D, Wright Z, Couzens A, Lambert J, St-Denis N, Li T . The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat Methods. 2013; 10(8):730-6. PMC: 3773500. DOI: 10.1038/nmeth.2557. View

Savitski M, Reinhard F, Franken H, Werner T, Falth Savitski M, Eberhard D . Tracking cancer drugs in living cells by thermal profiling of the proteome. Science. 2014; 346(6205):1255784. DOI: 10.1126/science.1255784. View

Ichikawa K, Ito M, Hartshorne D . Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity. J Biol Chem. 1996; 271(9):4733-40. DOI: 10.1074/jbc.271.9.4733. View

Dhillon A, Pollock C, Steen H, Shaw P, Mischak H, Kolch W . Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol Cell Biol. 2002; 22(10):3237-46. PMC: 133783. DOI: 10.1128/MCB.22.10.3237-3246.2002. View

Theurillat J, Metzler S, Henzi N, Djouder N, Helbling M, Zimmermann A . URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell. 2011; 19(3):317-32. DOI: 10.1016/j.ccr.2011.01.019. View

Balan V, Leicht D, Zhu J, Balan K, Kaplun A, Singh-Gupta V . Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase. Mol Biol Cell. 2006; 17(3):1141-53. PMC: 1382304. DOI: 10.1091/mbc.e04-12-1123. View

Sleeman J, Lamond A . Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells. J Cell Sci. 2001; 114(Pt 23):4219-28. DOI: 10.1242/jcs.114.23.4219. View

10.

Choy M, Moon T, Ravindran R, Bray J, Robinson L, Archuleta T . SDS22 selectively recognizes and traps metal-deficient inactive PP1. Proc Natl Acad Sci U S A. 2019; 116(41):20472-20481. PMC: 6789808. DOI: 10.1073/pnas.1908718116. View

11.

Heroes E, Lesage B, Gornemann J, Beullens M, Meervelt L, Bollen M . The PP1 binding code: a molecular-lego strategy that governs specificity. FEBS J. 2012; 280(2):584-95. DOI: 10.1111/j.1742-4658.2012.08547.x. View

12.

Geetha T, Langlais P, Caruso M, Yi Z . Protein phosphatase 1 regulatory subunit 12A and catalytic subunit δ, new members in the phosphatidylinositide 3 kinase insulin-signaling pathway. J Endocrinol. 2012; 214(3):437-43. PMC: 4445742. DOI: 10.1530/JOE-12-0145. View

13.

Du J, Xiang Y, Liu H, Liu S, Kumar A, Xing C . RIPK1 dephosphorylation and kinase activation by PPP1R3G/PP1γ promote apoptosis and necroptosis. Nat Commun. 2021; 12(1):7067. PMC: 8642546. DOI: 10.1038/s41467-021-27367-5. View

14.

Vit G, Duro J, Rajendraprasad G, Hertz E, Holland L, Weisser M . Chemogenetic profiling reveals PP2A-independent cytotoxicity of proposed PP2A activators iHAP1 and DT-061. EMBO J. 2022; 41(14):e110611. PMC: 9289710. DOI: 10.15252/embj.2022110611. View

15.

Wu W, Wang X, Berleth N, Deitersen J, Wallot-Hieke N, Bohler P . The Autophagy-Initiating Kinase ULK1 Controls RIPK1-Mediated Cell Death. Cell Rep. 2020; 31(3):107547. DOI: 10.1016/j.celrep.2020.107547. View

16.

Ceulemans H, Vulsteke V, De Maeyer M, Tatchell K, Stalmans W, Bollen M . Binding of the concave surface of the Sds22 superhelix to the alpha 4/alpha 5/alpha 6-triangle of protein phosphatase-1. J Biol Chem. 2002; 277(49):47331-7. DOI: 10.1074/jbc.M206838200. View

17.

Dougherty M, Muller J, Ritt D, Zhou M, Zhou X, Copeland T . Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell. 2005; 17(2):215-24. DOI: 10.1016/j.molcel.2004.11.055. View

18.

Djouder N, Metzler S, Schmidt A, Wirbelauer C, Gstaiger M, Aebersold R . S6K1-mediated disassembly of mitochondrial URI/PP1gamma complexes activates a negative feedback program that counters S6K1 survival signaling. Mol Cell. 2007; 28(1):28-40. DOI: 10.1016/j.molcel.2007.08.010. View

19.

Marklund U, Brattsand G, Osterman O, Ohlsson P, Gullberg M . Multiple signal transduction pathways induce phosphorylation of serines 16, 25, and 38 of oncoprotein 18 in T lymphocytes. J Biol Chem. 1993; 268(34):25671-80. View

20.

Chatterjee J, Beullens M, Sukackaite R, Qian J, Lesage B, Hart D . Development of a peptide that selectively activates protein phosphatase-1 in living cells. Angew Chem Int Ed Engl. 2012; 51(40):10054-9. PMC: 3531619. DOI: 10.1002/anie.201204308. View